Clinical effect of acupuncture treatment in obese people complicated with hyperlipidaemia: a randomised controlled study

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Participants who meet the diagnostic criteria of obesity, that is BMI between 28kg/m2 and 35 kg/m2;
•2. Participants who meet the diagnostic criteria of hyperlipidaemia, including hypercholesterolemia, hypertriglyceridemia, combined hyperlipidaemia and low HDL cholesterolemia and meeting any of the following dyslipidemias: 5.2 mmol/L<= TC < 6.2 mmol/L; 1.7 mmol/L<= TG <= 2.3 mmol/L; 3.4 mmol/L <= LDL-C < 4.1 mmol/L; 4.1 mmol/L <= Non-HDL-C < 4.9mmol/L; HDL-C < 1.0 mmol/L;
•3. Participants aged between 18 and 50 years;
•4. Participants who volunteer to the study and sign up for the informed consent.

•1. Secondary obesity;
•2. Women under lactation or pregnancy;
•3. Participants who suffered arteriosclerotic cardiovascular diseases (ASCVD), or complicated with high risk factors like hypertension, diabetes mellitus, or who are judged to be at middle risk or high risk degree of ASCVD, or need to take lipid lowering drugs by the judgement of physicians;
•4. Participants who complicated with severe primary diseases of important organs such as heart, liver and kidney;
•5. Participants who complicated with severe diseases such as hematological system disorders, infectious diseases, malignant tumors and so on;
•6. Participants who have taken weight-loss drugs within 3 months or have weight loss more than 5% within 3 months before enrollment;
•7. Participants who have taken lipid-lowering drugs within 3 months before enrollment;
•8. Participants who cannot cooperate with treatment of the study.

发起方

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine